Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Barry L. Dowell"'
Autor:
Julia S. Johansen, Hans Jørgen Nielsen, Emilie Hammer, Martin H. Hvolris, Lars N. Jorgensen, Nils Brünner, Jesper Olsen, Knud T. Nielsen, Gerard J. Davis, Søren Laurberg, Thomas B. Piper, Ib Jarle Christensen, Barry L. Dowell, Hans B Rahr
Publikováno v:
Hvolris, M H, Piper, T B, Hammer, E, Jorgensen, L N, Olsen, J, Rahr, H B, Nielsen, K T, Laurberg, S, Christensen, I J, Brunner, N, Johansen, J S, Davis, G J, Dowell, B L & Nielsen, H J 2016, ' Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer ', Scandinavian Journal of Gastroenterology, vol. 51, no. 7, pp. 860-865 . https://doi.org/10.3109/00365521.2016.1144783
Hvolris, M H, Piper, T B, Hammer, E, Jørgensen, L N, Olsen, J, Rahr, H B, Nielsen, K T, Laurberg, S, Christensen, I J, Brünner, N, Johansen, J S, Davis, G J, Dowell, B L & Nielsen, H J 2016, ' Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer (†) ', Scandinavian Journal of Gastroenterology, vol. 51, no. 7, pp. 860-5 . https://doi.org/10.3109/00365521.2016.1144783
Hvolris, M H, Piper, T B, Hammer, E, Jørgensen, L N, Olsen, J, Rahr, H B, Nielsen, K T, Laurberg, S, Christensen, I J, Brünner, N, Johansen, J S, Davis, G J, Dowell, B L & Nielsen, H J 2016, ' Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer (†) ', Scandinavian Journal of Gastroenterology, vol. 51, no. 7, pp. 860-5 . https://doi.org/10.3109/00365521.2016.1144783
Background: Frequently, subjects offered colonoscopy due to symptoms of colorectal neoplasia are diagnosed with diverticula. The symptoms may, however, also be related to extra-colonic neoplasia. The present retrospective study evaluated a possible a
Autor:
Arunava Chakravartty, Anahita Bhathena, Susan H. Gawel, Suresh S. Ramalingam, Dawn M. Carlson, Raj Chandran, Gerard J. Davis, Mark D. McKee, Barry L. Dowell, Sabrina S. Chan, Viswanath Devanarayan, Justin L. Ricker, Evelyn McKeegan, Peter Ansell
Publikováno v:
Lung Cancer. 90:296-301
Objectives Linifanib, a potent and selective inhibitor of the tyrosine kinase activity of vascular endothelial growth factor and platelet-derived growth factor receptors, has clinical activity in advanced non-small cell lung cancer (NSCLC) both as mo
Autor:
Ulf-Håkan Stenman, Francisco J. Esteva, Rafael Molina, Ie Ming Shih, Hans Jørgen Nielsen, Carsten Stephan, Michael J. Duffy, Lori J. Sokoll, Hans Lilja, Daniel W. Chan, Caj Haglund, Paul Sibley, Axel Semjonow, Nils Brünner, Nadia Harbeck, Daniel F. Hayes, Barry L. Dowell, George G. Klee, Harry G. Rittenhouse, Robert C. Bast, Leendert H. J. Looijenga, Rolf Lamerz, Barry Hoffman, Catharine M. Sturgeon, Mads Nikolaj Holten-Andersen, Eleftherios P. Diamandis, György Sölétormos, Richard J. Babaian
Publikováno v:
University of Helsinki
Background: Updated National Academy of Clinical Biochemistry (NACB) Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been developed.Methods: Published reports relevant to use of tumor markers for 5 cancer sites
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b737ea1564c10835360f51d51f29049
https://doi.org/10.1373/clinchem.2008.105601
https://doi.org/10.1373/clinchem.2008.105601
Autor:
Peter Ansell, Michelle Pedersen, Brian I. Carr, Barry L. Dowell, Wei Peng Yong, Evelyn McKeegan, Dawn M. Carlson, Qin Qin, Sharlene Gill, Jennifer J. Knox, Frank A. Scappaticci, Justin L. Ricker, Jiang Qian, Pei-Jer Chen, Han Chong Toh
Publikováno v:
Cancer. 119:380-387
BACKGROUND: The efficacy and safety of linifanib (ABT-869), a selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinases, were assessed in this phase 2, single-arm, open-label, multicenter t
Autor:
Edward B. Garon, Niki Rudersdorf, Geoffrey I. Shapiro, Quincy Chu, Barry L. Dowell, Todd A. Busman, Malcolm R Ranson, Moacyr Ribeiro de Oliveira, Brenda Chyla, Philip Bonomi, Leena Gandhi, Charles M. Rudin, Cathy E. Nolan, Divis Khaira, Giuseppe Giaccone, Caroline Dive, Evelyn McKeegan, Mack Mabry, D. Ross Camidge, Rod A. Humerickhouse, Andrew Krivoshik, Christine L. Hann, Suresh S. Ramalingam, Arunava Chakravartty
Publikováno v:
Clinical Cancer Research. 18:3163-3169
Purpose: Bcl-2 is a critical regulator of apoptosis that is overexpressed in the majority of small cell lung cancers (SCLC). Nativoclax (ABT-263) is a potent and selective inhibitor of Bcl-2 and Bcl-xL. The primary objectives of this phase IIa study
Autor:
Stanislav Spelda, Andrew Coates, Barry L. Dowell, Andrew Krivoshik, Jane Qian, Peter Ansell, Xiangdong Zhou, Gary S. Gordon, Rajendra S. Pradhan, Ann M. Mauer, Martin Šmakal, Evelyn McKeegan, Rosalyn A. Juergens, Charles M. Rudin, Michael S. Wertheim
Publikováno v:
Journal of Clinical Oncology. 29:1075-1082
Purpose ABT-751 is an antimitotic and vascular disrupting agent with potent preclinical anticancer activity. We conducted a phase I and randomized double-blind phase II study of pemetrexed with ABT-751 or placebo in patients with recurrent advanced o
Publikováno v:
Clinical Chemistry. 54:1951-1960
Background: Early detection of prostate cancer (CaP), the most prevalent cancer and the second-leading cause of death in men, has proved difficult, and current detection methods are inadequate. Prostate-specific antigen (PSA) testing is a significant
Autor:
Barry L. Dowell, Toru Yoshimura, Sabrina S. Chan, Gangamani S. Beligere, Katsumichi Takeda, Kenju Fujita, Satoshi Kawakami
Publikováno v:
Tumor Biology. 29:224-230
Although serum assays for pro-gastrin-releasing peptide (ProGRP) assays have been commercially available in Japan for several years, the stability of ProGRP in serum and plasma has not been well documented. We investigated the stability of ProGRP in
Autor:
Marie Dresse, Petra Stieber, Barry L. Dowell, Robert Doss, Eva-Maria Ganser, Dorothea Nagel, Gerard J. Davis
Publikováno v:
Tumor Biology. 29:35-40
Tissue inhibitor of metalloproteinases-1 (TIMP-1) in blood might be a helpful biomarker in various diseases. However, various authors report that TIMP-1 is dependent on preanalytical procedures. Our study was performed to determine how storage condit
Autor:
Nanna Møller Sørensen, Nils Brünner, James Lally, Barry L. Dowell, Ambika Weerakoon, Gerard J. Davis, Brian C. Rodgers, Stuart Blincko, Emma Dinsmore, Vibeke Jensen, Hans Jørgen Nielsen, Ib Jarle Christensen
Publikováno v:
Tumor Biology. 27:319-328
It has previously been shown that increased levels of plasma tissue inhibitor of metalloproteinase 1 (TIMP-1) is associated with shorter survival for patients with colorectal cancer (CRC). Furthermore, plasma TIMP-1 levels have been found to be eleva